EA
GILD icon

Edge Advisors’s Gilead Sciences GILD Stock Holding History

Edge Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$104K Sell
1,485
-122
-8% -$8.62K 0.01% 395
2018
Q1 		$120K Buy
1,607
+267
+20% +$21.2K 0.01% 383
2017
Q4 		$95K Buy
1,340
+300
+29% +$22.8K 0.01% 405
2017
Q3 		$83K Buy
1,040
+365
+54% +$27.9K 0.01% 419
2017
Q2 		$47K Sell
675
-1,298
-66% -$86.4K 0.01% 516
2017
Q1 		$133K Buy
1,973
+982
+99% +$69.1K 0.02% 369
2016
Q4 		$70K Buy
+991
New +$73.7K 0.01% 427

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Edge Advisors's GILD Position: Q2 2018 in Review

Edge Advisors reduced its Gilead Sciences (GILD) stake by 7.6% in Q2 2018, selling an estimated $8.62K and leaving 1,485 shares worth $104K. The position accounts for 0.01% of the portfolio, ranked #395.

Edge Advisors first reported a position in GILD in Q4 2016 and has held it in 7 quarters since. The position peaked at $133K in Q1 2017. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Edge Advisors held 1,485 shares of Gilead Sciences worth $104K as of Q2 2018.
  • Edge Advisors sold 122 Gilead Sciences shares in Q2 2018, an estimated $8.62K.
  • Gilead Sciences made up 0.01% of Edge Advisors's portfolio in Q2 2018, its #395 holding.
  • Edge Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Gilead Sciences position peaked at $133K in Q1 2017.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.